Literature DB >> 10859377

The rate of progression to AIDS is independent of virus dose in simian immunodeficiency virus-infected macaques.

L Holterman1, H Niphuis, W Koornstra, R Dubbes, P ten Haaft, J L Heeney.   

Abstract

Of the viral factors that are proposed to influence the rate of progression to AIDS, the role of infectious dose remains unresolved. Intravenous infection of outbred Macaca mulatta with various doses of simian immunodeficiency virus isolate 8980 (SIV(8980)) revealed an endpoint from which an infectious dose 50 (ID(50)) was defined. In the six infected animals, the time to develop AIDS was variable with a spectrum of rapid, intermediate and slow progressors. High and sustained plasma viraemia with marked loss of CD4(+) T-cells was a distinguishing feature between rapid versus intermediate and slow progressors. Animals that received the highest doses did not develop the highest sustained viral loads, nor did they progress more rapidly to disease. Similarly, animals infected with lower doses did not uniformly develop lower viral loads or progress more slowly to AIDS. Furthermore, compiled data from more than 21 animals infected with different doses of the same virus administered by the same route failed to reveal any correlation of infectious dose with survival. Indeed, host factors of these outbred animals, rather than dose of the initial inoculum, were probably an important factor influencing the rate of disease progression in each individual animal. Comparison of animals infected with SIV(B670), from which SIV(8980) was derived, revealed marked differences in disease progression. Clearly, although dose did not influence viral loads nor disease progression, the virulence of the initial inoculum was a major determinant of the rate of progression to AIDS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10859377     DOI: 10.1099/0022-1317-81-7-1719

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  9 in total

1.  Induction of potent local cellular immunity with low dose X4 SHIV(SF33A) vaginal exposure.

Authors:  Silvana Tasca; Lily Tsai; Nataliya Trunova; Agegnehu Gettie; Mohammed Saifuddin; Rudolf Bohm; Lisa Chakrabarti; Cecilia Cheng-Mayer
Journal:  Virology       Date:  2007-06-15       Impact factor: 3.616

2.  Transmission of simian immunodeficiency virus SIVcpz and the evolution of infection in the presence and absence of concurrent human immunodeficiency virus type 1 infection in chimpanzees.

Authors:  Jonathan L Heeney; Erik Rutjens; Ernst J Verschoor; Henk Niphuis; Peter ten Haaft; Scott Rouse; Hazel McClure; Sunita Balla-Jhagjhoorsingh; Willy Bogers; Mary Salas; Kathy Cobb; Luc Kestens; David Davis; Guido van der Groen; Valerie Courgnaud; Martine Peeters; Krishna K Murthy
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Cognitive and motor deficits associated with HIV-2(287) infection in infant pigtailed macaques: a nonhuman primate model of pediatric neuro-AIDS.

Authors:  J M Worlein; J Leigh; K Larsen; L Kinman; A Schmidt; H Ochs; R J Y Ho
Journal:  J Neurovirol       Date:  2005-02       Impact factor: 2.643

4.  Characteristics of a pathogenic molecular clone of an end-stage serum-derived variant of simian immunodeficiency virus (SIV(F359)).

Authors:  L Holterman; R Dubbes; J Mullins; G Learn; H Niphuis; W Koornstra; G Koopman; E M Kuhn; A Wade-Evans; B Rosenwirth; J Haaijman; J Heeney
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys.

Authors:  Ivona Pandrea; Christopher Kornfeld; Mickael J-Y Ploquin; Cristian Apetrei; Abdourahmane Faye; Pierre Rouquet; Pierre Roques; François Simon; Françoise Barré-Sinoussi; Michaela C Müller-Trutwin; Ousmane M Diop
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 6.  The impact of viral and host elements on HIV fitness and disease progression.

Authors:  Kenneth R Henry; Jan Weber; Miguel E Quiñones-Mateu; Eric J Arts
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

7.  Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.

Authors:  Bénédicte Puissant; Michel Abbal; Antoine Blancher
Journal:  Immunogenetics       Date:  2003-07-23       Impact factor: 2.846

8.  Increased APOBEC3G and APOBEC3F expression is associated with low viral load and prolonged survival in simian immunodeficiency virus infected rhesus monkeys.

Authors:  Bianka Mussil; Ulrike Sauermann; Dirk Motzkus; Christiane Stahl-Hennig; Sieghart Sopper
Journal:  Retrovirology       Date:  2011-09-28       Impact factor: 4.602

9.  Altered immune responses in rhesus macaques co-infected with SIV and Plasmodium cynomolgi: an animal model for coincident AIDS and relapsing malaria.

Authors:  Jeffrey W Koehler; Michael Bolton; Amanda Rollins; Kirsten Snook; Eileen deHaro; Elizabeth Henson; Linda Rogers; Louis N Martin; Donald J Krogstad; Mark A James; Janet Rice; Billie Davison; Ronald S Veazey; Ramesh Prabhu; Angela M Amedee; Robert F Garry; Frank B Cogswell
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.